• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膦甲酸钠对病毒聚合酶的作用机制。

Mechanism of action of foscarnet against viral polymerases.

作者信息

Crumpacker C S

机构信息

Department of Infectious Diseases, Beth Israel Hospital, Boston, Massachusetts 02215.

出版信息

Am J Med. 1992 Feb 14;92(2A):3S-7S. doi: 10.1016/0002-9343(92)90329-a.

DOI:10.1016/0002-9343(92)90329-a
PMID:1371038
Abstract

Foscarnet is a pyrophosphate analogue with activity against herpesviruses, human immunodeficiency virus (HIV), and other RNA and DNA viruses. Foscarnet and its analogues achieve their antiviral effects via inhibition of viral polymerases, with such inhibition not being dependent on activation or phosphorylation of the compounds by viral or cellular proteins. Current evidence indicates that foscarnet interferes with exchange of pyrophosphate from deoxynucleoside triphosphate during viral replication by binding to a site on the herpesvirus DNA polymerase or HIV reverse transcriptase. Reviewed herein are basic findings regarding the mechanism of action and antiviral activity of foscarnet and the related compound phosphonoacetic acid (PAA), as well as findings regarding potential mechanisms of viral resistance and interactions with other antiviral agents.

摘要

膦甲酸钠是一种焦磷酸盐类似物,对疱疹病毒、人类免疫缺陷病毒(HIV)以及其他RNA和DNA病毒具有活性。膦甲酸钠及其类似物通过抑制病毒聚合酶来实现其抗病毒作用,这种抑制不依赖于病毒或细胞蛋白对化合物的激活或磷酸化。目前的证据表明,膦甲酸钠在病毒复制过程中通过与疱疹病毒DNA聚合酶或HIV逆转录酶上的一个位点结合,干扰焦磷酸从脱氧核苷三磷酸的交换。本文综述了关于膦甲酸钠和相关化合物膦酰乙酸(PAA)的作用机制和抗病毒活性的基本研究结果,以及关于病毒耐药性的潜在机制和与其他抗病毒药物相互作用的研究结果。

相似文献

1
Mechanism of action of foscarnet against viral polymerases.膦甲酸钠对病毒聚合酶的作用机制。
Am J Med. 1992 Feb 14;92(2A):3S-7S. doi: 10.1016/0002-9343(92)90329-a.
2
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).膦甲酸(PFA,膦甲酸钠)的抗病毒作用。
Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2.
3
Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs.膦甲酸及其他药物对HIV-1 RNA依赖性DNA聚合酶以及细胞DNA聚合酶α、β和γ的抑制作用。
J Antimicrob Chemother. 1988 Feb;21(2):151-61. doi: 10.1093/jac/21.2.151.
4
Clinical pharmacology: foscarnet.临床药理学:膦甲酸钠。
Am J Med. 1992 Feb 14;92(2A):8S-11S. doi: 10.1016/0002-9343(92)90330-e.
5
Antiviral therapy targeting viral polymerase.针对病毒聚合酶的抗病毒疗法。
Curr Pharm Des. 2006;12(11):1339-55. doi: 10.2174/138161206776361156.
6
Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.
Adv Enzyme Regul. 1991;31:85-97. doi: 10.1016/0065-2571(91)90010-j.
7
Inhibition of herpesvirus and human DNA polymerases by alpha-halogenated phosphonoacetates.
Biochem Pharmacol. 1987 Oct 1;36(19):3103-6. doi: 10.1016/0006-2952(87)90618-6.
8
Synthesis and antiviral properties of sterol phosphonoformates.膦酰甲酸甾醇酯的合成及其抗病毒特性
Biochem Soc Trans. 1994 Aug;22(3):353S. doi: 10.1042/bst022353s.
9
Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo.更昔洛韦与膦甲酸钠联合使用在体外和体内对巨细胞病毒和2型单纯疱疹病毒的疗效增强。
Antiviral Res. 1989 Nov;12(4):205-12. doi: 10.1016/0166-3542(89)90030-2.
10
In vitro inhibition of human herpesvirus-6 by phosphonoformate.膦甲酸对人疱疹病毒6型的体外抑制作用
J Virol Methods. 1988 Sep;21(1-4):301-4. doi: 10.1016/0166-0934(88)90075-4.

引用本文的文献

1
Anti-Herpes Simplex Virus (Wild-Type and Drug-Resistant) Properties of Herbal Kerra, KS, and Minoza.草药Kerra、KS和米诺扎的抗单纯疱疹病毒(野生型和耐药型)特性。
Viruses. 2025 Jun 24;17(7):889. doi: 10.3390/v17070889.
2
Tackling CMV in Transplant Recipients: Past, Present, and Future.应对移植受者中的巨细胞病毒:过去、现在与未来
Infect Dis Ther. 2025 Apr 27. doi: 10.1007/s40121-025-01159-6.
3
Tackling cutaneous herpes simplex virus disease with topical immunomodulators-a call to action.使用局部免疫调节剂治疗皮肤单纯疱疹病毒疾病——行动呼吁
Clin Microbiol Rev. 2025 Mar 13;38(1):e0014724. doi: 10.1128/cmr.00147-24. Epub 2025 Feb 21.
4
The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses.γ疱疹病毒引发的γ细胞癌变——“祖母”因素
Viruses. 2024 Dec 17;16(12):1928. doi: 10.3390/v16121928.
5
The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification.动力蛋白抑制剂dynasore通过部分阻断唑来膦酸摄取并抑制内体酸化,防止唑来膦酸诱导的人牙龈成纤维细胞活力丧失。
J Appl Oral Sci. 2024 Sep 30;32:e20240224. doi: 10.1590/1678-7757-2024-0224. eCollection 2024.
6
Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.了解巨细胞病毒周期蛋白依赖性激酶同源物 pUL97 作为一个多方面的调节剂和抗病毒药物靶点。
Cells. 2024 Aug 13;13(16):1338. doi: 10.3390/cells13161338.
7
Phosphonoalamides Reveal the Biosynthetic Origin of Phosphonoalanine Natural Products and a Convergent Pathway for Their Diversification.膦酰氨类揭示了磷酰丝氨酸天然产物的生物合成起源和它们多样化的趋同途径。
Angew Chem Int Ed Engl. 2024 Aug 5;63(32):e202405052. doi: 10.1002/anie.202405052. Epub 2024 Jul 9.
8
Anti-N-methyl-D-aspartate receptor encephalitis 8 years after serial herpes simplex virus type 1 and human herpesvirus type 7 encephalitis.1型单纯疱疹病毒和7型人类疱疹病毒脑炎反复发作8年后发生抗N-甲基-D-天冬氨酸受体脑炎。
Encephalitis. 2021 Jan;1(1):25-29. doi: 10.47936/encephalitis.2020.00066. Epub 2020 Dec 23.
9
Cytomegalovirus infection induces Alzheimer's disease-associated alterations in tau.巨细胞病毒感染诱导 tau 发生与阿尔茨海默病相关的改变。
J Neurovirol. 2023 Aug;29(4):400-415. doi: 10.1007/s13365-022-01109-9. Epub 2023 Jul 12.
10
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients.异基因造血细胞移植受者普瑞巴林治疗难治性单纯疱疹病毒口腔病变。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0173222. doi: 10.1128/aac.01732-22. Epub 2023 Mar 27.